Medtronic PLC (NYSE:MDT)
$ 82.84 0.08 (0.1%) Market Cap: 110.00 Bil Enterprise Value: 126.86 Bil PE Ratio: 26.38 PB Ratio: 2.13 GF Score: 80/100

Medtronic PLC at Morgan Stanley Healthcare Conference Transcript

Sep 10, 2019 / 02:35PM GMT
Release Date Price: $107.48 (-0.42%)
David Ryan Lewis
Morgan Stanley, Research Division - MD

(technical difficulty)

here as we progress through the morning. My name is David Lewis, medical device analyst at Morgan Stanley. It's my pleasure to have with us here the CEO of Medtronic, Omar Ishrak.

Questions & Answers

David Ryan Lewis
Morgan Stanley, Research Division - MD

And I thought, Omar, just given the recent news, we kind of start off with probably the most important question. Obviously, you've announced your transition and retirement. So I guess the best question will be -- you've also named a successor. Why was Geoff Martha -- as you know, Geoff Martha ran a division for Medtronic, the RTG business. Why is Geoff the right choice to continue on as -- and run Medtronic?

Omar S. Ishrak
Medtronic plc - Chairman & CEO

Yes. Well, first, let me give a little perspective on the process and some of the philosophies. This was a process that the Board went through last 4, 5 years with increasing intensity as time went by. I knew

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot